We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senator: FDA Should Ramp Up Oversight of Outsourcing
Senator: FDA Should Ramp Up Oversight of Outsourcing
July 8, 2011
The FDA needs to tighten its oversight of drug industry outsourcing in the wake of a recent report that found an increasing number of drugs sold in the U.S. are manufactured in part or wholly overseas, Sen. Sherrod Brown (D-Ohio) says.